Home / Auditor changes / PharmaCyte Biotech, Inc.
Filed 2026-10-16 路 Form 8-K 路 Accession 0001683168-26-007934 nano
Price before filing: $0.3574 (2026-10-15 close, split/dividend-adjusted)
Market cap at flag: $3.7M (2026-10-16) 路 Latest: $3.7M (2026-10-16)
| Window | PMCB | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | pending | pending | until 2026-11-15 | |
| 90 days | pending | pending | until 2027-01-14 | |
| 180 days | pending | pending | until 2027-04-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"(the "Company") dismissed CBIZ CPAs P.C. ("CBIZ CPAs") as the Company's independent registered public accounting firm, effective as of that date."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Former auditor: CBIZ CPAs P.C. · New auditor: Grassi & Co., CPAs, P.C.
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.